MAY 30, 2014 10:30 AM PDT
Are we able to amplify single bacterial/viral/fungal genome equivalent?
Presented at the Clinical Diagnostics and Research Virtual Event
2 8

Speakers:
  • Head of Molecular Microbiology Unit- Molecular Biology, Jewish General Hospital - McGill University

Abstract:
There is growing pressure to implement new generation sequencing platform in hospital emergency rooms. The utility would be obvious: identifying unknown pathogens form cerebrospinal fluid/plasma/body fluids and guiding next step in therapy. What is exactly preventing us in taking this step, if we know that billions of dollars is/was spent on revealing cancer-relevant sequence-signatures using the same technology? And one vanishes from cancer much slower comparing to 24-48h time-window of life under unrelieved life-threatening infection. What went wrong in cashing in technological advance?

Show Resources
Loading Comments...
Show Resources